Bladder Directed vs. Pelvic Floor Therapy in IC/BPS

Status Recruiting

Clinical Trial Summary

Women with interstitial cystitis/bladder pain syndrome (IC/BPS) have debilitating urinary frequency and urgency, and chronic pelvic or bladder pain perceived to be related to the bladder. Although many clinicians think that IC/BPS symptoms result from a bladder problem, tight pelvic floor muscles can cause similar symptoms and might be responsible for ICBPS symptoms instead of the bladder. Inadequate assessment of the problem leads to delays in treatment and often years of suffering. This clinical trial will test a bladder directed therapy (bladder instillations) compared to a course of pelvic floor physical therapy (PFPT) to assess the role of the pelvic floor as a major contributor to pelvic pain and voiding dysfunction in adult women with non-ulcerative IC/BPS. Early assessment of the pelvic floor muscles in patients with IC/BPS symptoms may prevent common delays in proper diagnosis and allow for early, more effective treatment.

Clinical Trial Description

This will be a prospective randomized trial of pelvic floor therapy vs. bladder directed therapy. The study target population consists of females, aged 18 to 85 years of age with a clinical diagnosis of IC/BPS and symptoms of chronic urinary frequency, pelvic pain/discomfort, and/or urinary urgency. The approximate number of subjects that will be enrolled in the study is 128, 64 women in each treatment group. Women who satisfy all of the eligibility criteria will be enrolled in the study and randomized to receive bladder treatments (instillation of medications into the bladder) or pelvic floor physical therapy. Outcome measures will include validated questionnaires, voiding diaries, and Global Response Assessment (GRA). The investigators also will evaluate changes in pelvic floor muscle tone and discomfort pre and post treatment, and their relationship to symptom changes. Finally, the investigators will utilize their well-established urine and serum biomarkers evaluations pre and post treatment to determine if they correlate with symptom change. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02870738
Study type	Interventional
Source	William Beaumont Hospitals
Contact	Lydia Kosovich, RN
Phone	248-551-3291
Email	Lydia.Kosovich@Beaumont.org
Status	Recruiting
Phase	Phase 2
Start date	April 21, 2017
Completion date	August 2026

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04313972` - IC PaIN Trial: Interstitial Cystitis Pain Improvement With Naltrexone	Phase 4
Recruiting	`NCT02868775` - A Study to Determine the Role of Toll-like Receptor-4 Expression in Patients With Interstitial Cystitis/Bladder Pain Syndrome	N/A
Not yet recruiting	`NCT01410461` - Identifying Predictors of Treatment Success in Painful Bladder Syndrome	N/A
Completed	`NCT01197261` - OXN PR vs Placebo in Opioid-naive Subjects Suffering From Severe Pain Due to Bladder Pain Syndrome (BPS)	Phase 2
Completed	`NCT00150488` - URACYST® For the Treatment of GAG Deficient Interstitial Cystitis	N/A
Completed	`NCT00672087` - Diagnostic Challenges in IC (and Male CPPS)
Completed	`NCT02232282` - Acupuncture for Female IC/PBSyndrome and Its Effect on the Urinary Microbiome: A Randomized Controlled Trial	N/A
Completed	`NCT00775281` - Changes in Inflammatory and Contractile Protein Expression in Patients With Painful Bladder Syndrome/IC.	N/A
Completed	`NCT05223244` - Bladder Capacity as Objective Measure of Intravesical Treatment of Newly Diagnosed IC	Phase 4
Completed	`NCT02600715` - Reduction of Bladder Injection Pain With Belladonna Opiate Suppository	Phase 4
Completed	`NCT02457182` - Mindfulness-Based Therapy for Interstitial Cystitis/Bladder Pain Syndrome	N/A
Withdrawn	`NCT03027076` - Microbiome of Urologic Chronic Pelvic Pain Syndrome	N/A
Completed	`NCT00434343` - Physical Therapy Trial for Pelvic Pain	N/A
Terminated	`NCT03143920` - Hyperbaric Oxygen Therapy for Inflammatory Conditions of the Urinary Bladder	Early Phase 1
Completed	`NCT02411110` - A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome	Phase 2
Completed	`NCT00903643` - Sensory Processing in Subjects With Painful Bladder Syndrome	N/A
Completed	`NCT00194610` - Botox as a Treatment for Interstitial Cystitis in Women	Phase 4
Recruiting	`NCT06299683` - Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment	N/A
Terminated	`NCT04268810` - Prospective Trial Comparing Intravesical Chondroitin Sulphate 2% and DMSO in the Treatment of PBS/Interstitial Cystitis	Phase 4
Completed	`NCT01294878` - Omalizumab in Interstitial Cystitis/Bladder Pain Syndrome	Phase 3

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.